MetLife Investment Management’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.91M | Sell |
36,520
-808
| -2% | -$48.5K | 0.01% | 1082 |
|
|
2025
Q4 | $2.2M | Sell |
37,328
-1,568
| -4% | -$95.3K | 0.01% | 1031 |
|
|
2025
Q3 | $2.16M | Sell |
38,896
-1,046
| -3% | -$56K | 0.01% | 1050 |
|
|
2025
Q2 | $2.06M | Sell |
39,942
-1,096
| -3% | -$55.1K | 0.01% | 975 |
|
|
2025
Q1 | $2.41M | Sell |
41,038
-950
| -2% | -$64.4K | 0.01% | 955 |
|
|
2024
Q4 | $3.02M | Buy |
41,988
+1,055
| +3% | +$77.5K | 0.02% | 825 |
|
|
2024
Q3 | $3.27M | Sell |
40,933
-1,055
| -3% | -$79.3K | 0.02% | 769 |
|
|
2024
Q2 | $3.01M | Sell |
41,988
-846
| -2% | -$62.3K | 0.02% | 774 |
|
|
2024
Q1 | $3.02M | Sell |
42,834
-1,546
| -3% | -$111K | 0.02% | 781 |
|
|
2023
Q4 | $3.42M | Sell |
44,380
-631
| -1% | -$41.6K | 0.02% | 700 |
|
|
2023
Q3 | $3.06M | Sell |
45,011
-1,018
| -2% | -$80.4K | 0.02% | 697 |
|
|
2023
Q2 | $3.76M | Sell |
46,029
-726
| -2% | -$58.4K | 0.03% | 628 |
|
|
2023
Q1 | $3.47M | Sell |
46,755
-397
| -0.8% | -$30.6K | 0.02% | 661 |
|
|
2022
Q4 | $3.91M | Sell |
47,152
-932
| -2% | -$74K | 0.03% | 576 |
|
|
2022
Q3 | $3.41M | Sell |
48,084
-536
| -1% | -$46.3K | 0.03% | 617 |
|
|
2022
Q2 | $4.21M | Sell |
48,620
-1,116
| -2% | -$105K | 0.03% | 529 |
|
|
2022
Q1 | $5.38M | Buy |
49,736
+15,004
| +43% | +$1.55M | 0.03% | 478 |
|
|
2021
Q4 | $4.49M | Sell |
34,732
-404
| -1% | -$49.5K | 0.04% | 454 |
|
|
2021
Q3 | $4.26M | Sell |
35,136
-42,600
| -55% | -$5.18M | 0.04% | 456 |
|
|
2021
Q2 | $8.75M | Sell |
77,736
-2,432
| -3% | -$256K | 0.08% | 215 |
|
|
2021
Q1 | $7.65M | Sell |
80,168
-4,344
| -5% | -$396K | 0.07% | 246 |
|
|
2020
Q4 | $6.71M | Sell |
84,512
-3,776
| -4% | -$273K | 0.06% | 270 |
|
|
2020
Q3 | $5.47M | Sell |
88,288
-2,508
| -3% | -$163K | 0.06% | 298 |
|
|
2020
Q2 | $5.99M | Buy |
90,796
+3,288
| +4% | +$197K | 0.07% | 256 |
|
|
2020
Q1 | $4.15M | Hold |
87,508
| – | – | 0.06% | 310 |
|
|
2019
Q4 | $4.8M | Sell |
87,508
-1,048
| -1% | -$55K | 0.05% | 369 |
|
|
2019
Q3 | $4.33M | Sell |
88,556
-1,200
| -1% | -$60.2K | 0.05% | 393 |
|
|
2019
Q2 | $4.68M | Sell |
89,756
-2,328
| -3% | -$117K | 0.05% | 379 |
|
|
2019
Q1 | $4.57M | Sell |
92,084
-28
| -0% | -$1.26K | 0.05% | 376 |
|
|
2018
Q4 | $3.33M | Sell |
92,112
-288
| -0.3% | -$12K | 0.04% | 482 |
|
|
2018
Q3 | $4.71M | Sell |
92,400
-2,060
| -2% | -$91.2K | 0.05% | 385 |
|
|
2018
Q2 | $3.49M | Buy |
94,460
+916
| +1% | +$35K | 0.04% | 515 |
|
|
2018
Q1 | $3.53M | Sell |
93,544
-1,268
| -1% | -$44.8K | 0.04% | 511 |
|
|
2017
Q4 | $3.07M | Buy |
+94,812
| New | +$3.01M | 0.03% | 624 |
|
Other funds holding TECH
VCM
VPM
MC
MetLife Investment Management's TECH Position: Q1 2026 in Review
MetLife Investment Management reduced its Bio-Techne (TECH) stake by 2.2% in Q1 2026, selling an estimated $48.5K and leaving 36,520 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #1082.
MetLife Investment Management first reported a position in TECH in Q4 2017 and has held it in 34 quarters since. The position peaked at $8.75M in Q2 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- MetLife Investment Management held 36,520 shares of Bio-Techne worth $1.91M as of Q1 2026.
- MetLife Investment Management sold 808 Bio-Techne shares in Q1 2026, an estimated $48.5K.
- Bio-Techne made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1082 holding.
- MetLife Investment Management first reported a position in Bio-Techne in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Bio-Techne position peaked at $8.75M in Q2 2021.
- 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.